Mehrkosten durch die Einführung vertraulicher Erstattungsbeträge für die GKV

This question concerns the additional costs incurred by Germany's statutory health insurance system due to the introduction of confidential reimbursement schemes. It seeks to understand the financial impact on the health insurance system and potentially on patients.